Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered follow-on offering of 3,214,250 shares of common stock of AVITA Medical, Inc., including the full exercise by the underwriters of their option to purchase additional shares of common stock. The common stock is listed on the Nasdaq Stock Market LLC under the symbol “RCEL.”
Based in Valencia, California, AVITA Medical is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds and aesthetics indications. AVITA Medical’s proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth LeBow and Travis B. Mitchell. The tax team included partner Mario J. Verdolini and associate Shay Moyal. The intellectual property and technology transactions team included partner Frank J. Azzopardi and associate Mikaela Dealissia. Allison Gunther provided 1940 Act advice. Members of the Davis Polk team are based in the Northern California and New York offices.